Toggle Offcanvas
...
 
Bosutinib Tenders

Bosutinib Tenders

View Bosutinib tenders, RFPs and contracts. Bid on readily available Bosutinib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Bosutinib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Bosutinib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Bosutinib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Bosutinib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

132 Live Notices for Bosutinib Tenders

Showing 1 to 20

55Th Generics Tender_Fl
country Germany
posting date05 Feb 2025
deadline17 Mar 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Bosutinib (Atc Code According To Who: L01Ea04)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Bosutinib (Atc Code According To Who: L01Ea04)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Bosutinib (Atc Code According To Who: L01Ea04)
country Germany
posting date11 Nov 2024
deadline31 Dec 2025
Medicines Containing The Active Ingredient Bosutinib (Atc: L01Ea04)
country Germany
posting date23 Oct 2024
deadline30 Sep 2026
Open House Award 2024-4
country Germany
posting date22 Oct 2024
deadline30 Nov 2026
Open House Drug Discount Agreements Bosutinib, Atc L01Ea04
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Open House Drug Discount Agreements Bosutinib, Atc L01Ea04
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib (L01Ea04) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date18 Sep 2024
deadline31 Aug 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib (L01Ea04) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date17 Sep 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib (Atc Code: L01Ea04).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib (Atc Code: L01Ea04).
country Germany
posting date14 Sep 2024
deadline27 Aug 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026
Pharmaceutical Discount Agreements From 1 November 2024 For Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date09 Sep 2024
deadline01 Sep 2026

Share Share this page